伊布迪拉斯特保护视网膜双极细胞免受刺激毒性视网膜损伤,并激活mTOR通路
Sumaya Hamadmad1, Tyler Heisler-Taylor1, Sandeep Goswami1
1Department of Ophthalmology and Visual Sciences, Havener Eye Institute, The Ohio State University, Wexner Medical Center, Columbus, Ohio, USA.
Glia
|February 7, 2025
概括
伊布迪拉斯特通过抑制固酶 (PDE) 和巨细胞迁移抑制因子 (MIF) 来保护视网膜神经元免受损伤. 这种药物在治疗视网膜疾病和保持视力方面表现有前途.
科学领域:
- 神经科学是一个神经科学.
- 眼科医生 眼科 眼科
- 药理学 药理学是指药理学的学科.
背景情况:
- 伊布迪拉斯特是一种神经保护剂,可以抑制巨细胞迁移抑制因子 (MIF) 和化酶 (PDE).
- 视网膜损伤模型对于理解神经保护策略至关重要.
- 单细胞RNA测序 (scRNA-seq) 提供了对细胞反应的高分辨率洞察力.
研究的目的:
- 在小刺激毒性视网膜损伤模型中研究ibudilast的神经保护潜力.
- 阐明MIF和PDE抑制在ibudilast视网膜效应中的作用.
- 为了确定涉及ibudilast介导神经保护的分子通路.
主要方法:
- 刺激毒性视网膜损伤模型.
- 内注射伊布迪拉斯特.
- 单细胞RNA测序 (scRNA-seq). 在一个单细胞RNA测序.
- 光谱域光学连贯性断层扫描 (SD-OCT).
- 电网膜学 (ERG). 电网膜学.
主要成果:
- 伊布迪拉斯特耐受性良好,并保护内核层神经元免受NMDA诱导的死亡.
- 抑制PDE对于ibudilast的神经保护作用至关重要,与其类似物AV1013.不同.
- scRNA-seq揭示了伊布迪拉斯提升了米勒质细胞和双极细胞中的mTOR信号传递.
- 灵受体分析表明,双极细胞和穆勒细胞之间的交叉声调是重要的.
结论:
- 在临床前模型中,Ibudilast有效地保护视网膜神经元并保持视觉功能.
- 抑制PDE对于ibudilast在视网膜中的神经保护作用至关重要.
- 伊布迪拉斯特在治疗视网膜损伤和疾病方面显示出临床翻译的潜力.
相关概念视频
01:22PI3K/mTOR/AKT Signaling Pathway
3.4K
The mammalian target of rapamycin (mTOR) is a serine/threonine kinase that regulates growth, proliferation, and cell survival in response to hormones, growth factors, or nutrient availability. This kinase exists in two structurally and functionally distinct forms: mTOR complex 1 (mTORC1) and mTOR complex 2 (mTORC2). The first form (mTORC1) is composed of a rapamycin-sensitive Raptor and proline-rich Akt substrate, PRAS40. In contrast, mTORC2 consists of a...
3.4K
03:03mTOR Signaling and Cancer Progression
3.7K
The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
The mTOR pathway or the...
3.7K
02:34Inhibition of Cdk Activity
4.6K
The orderly progression of the cell cycle depends on the activation of Cdk protein by binding to its cyclin partner. However, the cell cycle must be restricted when undergoing abnormal changes. Most cancers correlate to the deregulated cell cycle, and since Cdks are a central component of the cell cycle, Cdk inhibitors are extensively studied to develop anticancer agents. For instance, cyclin D associates with several Cdks, such as Cdk 4/6, to form an active complex. The cyclin D-Cdk4/6 complex...
4.6K
01:22iPS Cell Differentiation
2.6K
The ability of induced pluripotent stem cells or iPSCs to differentiate into most body cell types has stimulated repair and regenerative medicine research over the past few decades. iPSC-derived blood cells, hepatocytes, beta islet cells, cardiomyocytes, neurons, and other cell types can repair injuries or regenerate damaged tissue in diseases such as diabetes and neurodegenerative disorders.
2.6K
01:31Regulation of the Unfolded Protein Response
2.4K
Inositol-requiring kinase one or IRE1 is the most conserved eukaryotic unfolded protein response (UPR) receptor. It is a type I transmembrane protein kinase receptor with a distinctive site-specific RNase activity. As the binding mechanics of the misfolded proteins with the N-terminal domain of IRE-1 are unclear, three binding models — direct, indirect, and allosteric -- are proposed for receptor activation. Nevertheless, it is known that once a misfolded protein associates with IRE1, it...
2.4K